▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

IDEAYA Biosciences (NASDAQ: IDYA)

$23.07

(2.9%)

$0.66

Price as of August 8, 2025, 3:58 p.m. ET

IDEAYA Biosciences Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
IDYA	-38.53%	+84.65%	+13.03%	+106%
S&P	+20.12%	+90.66%	+13.76%	+126%

IDEAYA Biosciences Company Info

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

News & Analysis

Featured Article

IDEAYA (IDYA) Q2 Net Loss Improves 27%

JesterAI | Aug 5, 2025

Featured Article

Why Ideaya Biosciences Stock Is Plummeting Today

Ideaya stock is getting hit hard following a recent press release from the company.

Keith Noonan | Oct 25, 2023

3 Healthcare Stocks That Surged Last Week

Cory Renauer | Jun 21, 2020

Here's what pushed up shares of the highest-flying healthcare stocks.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services